Abstract
The pharmacoepidemic analysis of 500 clinical charts of children aged 1 day to 15 years on the basis of 7 pediatric polyclinics is earned out. If the indications and quality of prescribing antibacterial drugs in acute respiratory viral infections are taken into account, their injustified use is established in 36,5% of the cases, the discrepancy between standard doses on a number of drugs is established in 3361,5% of the cases. This justifies the necessity of phamiacoepidemic monitoring of pharmacotherapy of patients with acute respiratory viral infections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
